Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

Condition:   Pregnancy Prevention Interventions:   Drug: Levonorgestrel 1.5mg;   Drug: Meloxicam 15 mg;   Other: Placebo Sponsors:   InnovaGyn, Inc.;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials